Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Consumer,Eribulin,Locally advanced or metastatic breast cancer (following progression on chemotherapy),Eribulin (Halaven),,Oncology Agents and Immunosuppressants
